Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk

NACompletedINTERVENTIONAL
Enrollment

1,035

Participants

Timeline

Start Date

December 14, 2011

Primary Completion Date

November 24, 2020

Study Completion Date

November 24, 2020

Conditions
Type 2 Diabetes
Interventions
OTHER

HbA1c measurement

OTHER

Oral Glucoce Tolerance Test

Oral Glucoce Tolerance Test

Trial Locations (17)

4000

CHU Sart Tilman Liège, Liège

13274

CHU Marseille Hôpitaux Sud, Marseille

14000

CHU de Caen, Caen

25030

CHU Jean Minjoz, Besançon

31403

CHU Toulouse, Toulouse

38043

University Hospital Grenoble, Grenoble

44000

CHU de Nantes, Nantes

54500

CHU de Nancy, Nancy

59037

CHRU Lille, Lille

67000

Centre Hospitalier Strasbourg, Strasbourg

75877

CHU Bichat, Paris

91000

CH Sud Francilien, Évry

93000

CHU Avicenne, Bobigny

94270

CHU de Bicetre, Le Kremlin-Bicêtre

Unknown

CHU de Bondy, Bondy

CHU de BREST, Brest

CHU de REIMS, Reims

All Listed Sponsors
lead

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

NCT01727349 - Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk | Biotech Hunter | Biotech Hunter